Replies to post #106156 on NanoViricides Inc. (NNVC)

[bloomvest]

NNVC is a dismal failure

The mice would survive a certain amount of days regardless (5 days). It is too small of a sample size to say this study showed any benefit at all. That is why they NNVC-werent selected for government ebola grants.
Ebolacide 2 is certain to be crap as well.

I would hardly describe raising survivability from 5 to 7 days a dismal failure. If Ebolacide 1 did that just think what Ebolacide 2 might do? Maybe 21 days, which is a CURE.

[Rawnoc]

"2014 is going to be a big year. We're finishing our pilot production plant...we're going to have our large scale toxicology results that are needed for the FDA -- Done. If everything goes well as it's been going we'll start our human trials at best by the end of next year, worst at the beginning of the following year [2015]." ~~Seymour, 12/13/13 with the stock price at $5.13 per share

People invested their life savings based on that bullshit. They weren't told buy and hold for the long term -- they were told 2014 would be a big year.

12/13/13: $5.13 stock price (date of interview)
12/31/13: $4.80 stock price
12/26/14: $2.75
12/31/15: $0.50 ?